FDA Approved: HEPARIN SODIUM IN SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter's Supplemental Application for Heparin Sodium in Sodium Chloride (Heparin Sodium), approving changes to an already-approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Disseminated Intravascular Coagulation
• Myocardial Infarction
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• HEPARIN SODIUM IN SODIUM CHLORIDE (heparin sodium in sodium chloride)

Snippet

SUPPL AP for HEPARIN SODIUM IN SODIUM CHLORIDE (HEPARIN SODIUM)